Kendra Adams - Sep 18, 2024 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Financial Officer
Signature
/s/ Shagha Russell, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Sep 18, 2024
Transactions value $
-$11,720
Form type
4
Date filed
9/20/2024, 04:13 PM
Previous filing
Sep 17, 2024
Next filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Tax liability -$11.7K -1.84K -2.2% $6.38 81.8K Sep 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the Reporting Person.